1009843-27-9

Basic information

• Product Name: 2-(8-benzyloxy-5-chloro-quinolin-7-yl)-1-(3-pyrrolidin-1-ylmethyl-phenyl)-ethanol
• Synonyms: 2-(8-benzyloxy-5-chloro-quinolin-7-yl)-1-(3-pyrrolidin-1-ylmethyl-phenyl)-ethanol
• CAS NO: 1009843-27-9
• Molecular Weight: 473.014
• Mol File: 1009843-27-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(8-benzyloxy-5-chloro-quinolin-7-yl)-1-(3-pyrrolidin-1-ylmethyl-phenyl)-ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(8-benzyloxy-5-chloro-quinolin-7-yl)-1-(3-pyrrolidin-1-ylmethyl-phenyl)-ethanol(1009843-27-9)
• EPA Substance Registry System: 2-(8-benzyloxy-5-chloro-quinolin-7-yl)-1-(3-pyrrolidin-1-ylmethyl-phenyl)-ethanol(1009843-27-9)

Safety Data

• Hazardous Substances Data: 1009843-27-9(Hazardous Substances Data)

Upstream product

• 480424-79-1 [3-(1-pyrrolidinylmethyl)phenyl]magnesium bromide 
• 1009842-71-0 [8-(benzyloxy)-5-chloroquinolin-7-yl]acetaldehyde 

Relevant articles and documents

8-HYDROXYQUINOLINE COMPOUNDS AND METHODS THEREOF

The present invention relates to 8-Hydroxyquinoline Compounds; compositions comprising an 8-Hydroxyquinoline Compound; and methods for treating or preventing a metalloproteinase-related disorder, such as, an arthritic disorder, osteoarthritis, malignant neoplasm, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, atherosclerosis, age-related macular degeneration, myocardial infarction, a corneal ulceration, an ocular surface disease, hepatitis, an aortic aneurysm, tendonitis, a central nervous system disorder, abnormal wound healing, angiogenesis, restenosis, cirrhosis, multiple sclerosis, glomerulonephritis, graft versus host disease, diabetes, an inflammatory bowel disease, shock, invertebral disc degeneration, stroke, osteopenia or a periodontal disease or comprising administering an effective dose of an 8-Hydroxyquinoline Compound to a mammal in need thereof.